Promoter methylation of p16 associated with Helicobacter pylori infection in precancerous gastric lesions: a population-based study - PubMed (original) (raw)
. 2009 Jan 15;124(2):434-9.
doi: 10.1002/ijc.23891.
Affiliations
- PMID: 18821580
- DOI: 10.1002/ijc.23891
Promoter methylation of p16 associated with Helicobacter pylori infection in precancerous gastric lesions: a population-based study
Cai-Xuan Dong et al. Int J Cancer. 2009.
Abstract
To investigate the relationship between p16 methylation and Helicobacter pylori infection in precancerous gastric lesions, a population-based study was conducted in Linqu County, a high-risk area of gastric cancer in China. Methylation status of p16 was evaluated by methylation-specific polymerase chain reaction in 920 subjects with precancerous gastric lesions. H. pylori status was determined by 13C-urea breath test and the density of H. pylori in biopsy specimens used for detecting methylation status was assessed by the modified Giemsa stain. The frequency of p16 methylation was significantly higher in subjects with H. pylori positive than those with H. pylori negative in each category of gastric lesion (p<0.001, respectively). Compared with H. pylori negative, the odds ratios (ORs) of p16 methylation were markedly elevated in subjects with H. pylori positive for superficial gastritis (OR, 9.45; 95% confidence interval [CI]: 2.94-30.41), chronic atrophic gastritis (OR, 15.92; 95%CI: 7.60-33.36), intestinal metaplasia (OR, 4.46; 95%CI: 2.44-8.13), indefinite dysplasia (OR, 3.67; 95%CI: 1.90-7.10), and dysplasia (OR, 2.48; 95%CI: 1.02-5.99). Moreover, the frequencies of p16 methylation increased steadily with the severity of H. pylori density in gastric mucosa. Compared with H. pylori negative, the OR of p16 methylation was 1.02-16.13 times higher in subjects with mild H. pylori infection, and 2.69-38.73 times higher in those with moderate/severe infection, respectively. Our findings indicate that p16 methylation was significantly associated with H. pylori infection in precancerous gastric lesions, suggesting that H. pylori infection could potently induce methylation of p16 CpG island.
Copyright (c) 2008 Wiley-Liss, Inc.
Similar articles
- Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium.
Tahara T, Arisawa T, Shibata T, Wang FY, Nakamura M, Sakata M, Nagasaka M, Takagi T, Kamiya Y, Fujita H, Nakamura M, Hasegawa S, Iwata M, Takahama K, Watanabe M, Hirata I, Nakano H. Tahara T, et al. Digestion. 2007;75(1):54-61. doi: 10.1159/000101775. Epub 2007 Apr 16. Digestion. 2007. PMID: 17438355 - [The correlative analysis of indefinite dysplasia and dysplasia, and its p16 methylation in human gastric mucosa with Helicobacter pylori infection].
Dong CX, Deng da J, Zhou J, Zhang L, Ma JL, Pan KF, You WC. Dong CX, et al. Beijing Da Xue Xue Bao Yi Xue Ban. 2008 Jun 18;40(3):280-4. Beijing Da Xue Xue Bao Yi Xue Ban. 2008. PMID: 18560456 Chinese. - Helicobacter pylori-induced inflammation and epigenetic changes during gastric carcinogenesis.
Valenzuela MA, Canales J, Corvalán AH, Quest AF. Valenzuela MA, et al. World J Gastroenterol. 2015 Dec 7;21(45):12742-56. doi: 10.3748/wjg.v21.i45.12742. World J Gastroenterol. 2015. PMID: 26668499 Free PMC article. Review. - Apoptosis in gastric epithelium induced by Helicobacter pylori infection: implications in gastric carcinogenesis.
Xia HH, Talley NJ. Xia HH, et al. Am J Gastroenterol. 2001 Jan;96(1):16-26. doi: 10.1111/j.1572-0241.2001.03447.x. Am J Gastroenterol. 2001. PMID: 11197247 Review.
Cited by
- Epigenetic Mechanisms in Gastric Cancer: Potential New Therapeutic Opportunities.
Canale M, Casadei-Gardini A, Ulivi P, Arechederra M, Berasain C, Lollini PL, Fernández-Barrena MG, Avila MA. Canale M, et al. Int J Mol Sci. 2020 Jul 31;21(15):5500. doi: 10.3390/ijms21155500. Int J Mol Sci. 2020. PMID: 32752096 Free PMC article. Review. - Nucleosomes correlate with in vivo progression pattern of de novo methylation of p16 CpG islands in human gastric carcinogenesis.
Lu ZM, Zhou J, Wang X, Guan Z, Bai H, Liu ZJ, Su N, Pan K, Ji J, Deng D. Lu ZM, et al. PLoS One. 2012;7(4):e35928. doi: 10.1371/journal.pone.0035928. Epub 2012 Apr 25. PLoS One. 2012. PMID: 22558275 Free PMC article. - Towards incorporating epigenetic mechanisms into carcinogen identification and evaluation.
Herceg Z, Lambert MP, van Veldhoven K, Demetriou C, Vineis P, Smith MT, Straif K, Wild CP. Herceg Z, et al. Carcinogenesis. 2013 Sep;34(9):1955-67. doi: 10.1093/carcin/bgt212. Epub 2013 Jun 7. Carcinogenesis. 2013. PMID: 23749751 Free PMC article. Review. - Clinical aspect and molecular mechanism of DNA aneuploidy in gastric cancers.
Oki E, Hisamatsu Y, Ando K, Saeki H, Kakeji Y, Maehara Y. Oki E, et al. J Gastroenterol. 2012 Apr;47(4):351-8. doi: 10.1007/s00535-012-0565-4. Epub 2012 Mar 9. J Gastroenterol. 2012. PMID: 22402775 Review. - A functional polymorphism in the DNA methyltransferase-3A promoter modifies the susceptibility in gastric cancer but not in esophageal carcinoma.
Fan H, Liu D, Qiu X, Qiao F, Wu Q, Su X, Zhang F, Song Y, Zhao Z, Xie W. Fan H, et al. BMC Med. 2010 Feb 3;8:12. doi: 10.1186/1741-7015-8-12. BMC Med. 2010. PMID: 20128888 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical